Dergiler / Anadolu Kardiyoloji Dergisi / 2014 / Cilt: 14 - Sayı: 7

Results of radiofrequency ablation in children with tachycardia-induced cardiomyopathy

Sayfa
625–630
Yayın Tarihi
2022-10-10
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In 1 patient permanent complete AV block was developed after the procedure.Conclusion: Treatment of tachycardia with RFA, particularly in patients with arrhythmia refractory to medical therapy, is a feasible and effective treatment option regardless of age.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Tachycardia-induced cardiomyopathy (TIC) is a rare but potentially curable cause of dilated cardiomyopathy.
📊
Temel Bulgular & Veri:Methods: The medical records of patients with TIC and those underwent RFA between 2000-2011 were systematically reviewed.
💡
Sonuç & Katkı:In 1 patient permanent complete AV block was developed after the procedure.Conclusion: Treatment of tachycardia with RFA, particularly in patients with arrhythmia refractory to medical therapy, is a feasible and effective treatment option regardless of age.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2000-2011 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Tachycardia-induced cardiomyopathy (TIC) is a rare but potentially curable cause of dilated cardiomyopathy. Data on radiofrequency ablation (RFA) for TIC is limited. The aim of this study is to present our experience with RFA in children with TIC, retrospectively. Methods: The medical records of patients with TIC and those underwent RFA between 2000-2011 were systematically reviewed. Demographics and echocardiographic features were recorded. Tachycardia-induced cardiomyopathy is defined as dilatation of the heart chambers or heart failure with chronic or very frequent cardiac arrhythmia. Diagnosis was confirmed with normalization of functions after sinus rhythm has been achieved.Results: A total of 12 patients with a mean age of 6.3±4.1 years (in utero-11.5 years) at diagnosis were enrolled in the study consisting of 7 patients with permanent junctional reciprocating tachycardia and 5 patients with focal atrial tachycardia. The mean pre-RFA left ventricular end-diastolic diameter and left ventricular ejection fraction (LVEF) values were 49.1±9.6 mm and 40.8±13.4% (23-57%), respectively. One month after RFA, the mean LVEF value was 62±4.9% , with only 2 out of 12 patients' LVEF values were still lower than 58%. Tachycardia recurrence was observed in 4 patients, 3 of which had successful repeated RFA procedure. Overall, cure for arrhythmia was achieved in 11 patients (92%), while reversal of heart failure achieved in all patients. In 1 patient permanent complete AV block was developed after the procedure.Conclusion: Treatment of tachycardia with RFA, particularly in patients with arrhythmia refractory to medical therapy, is a feasible and effective treatment option regardless of age.

🔖

Bu Makaleye Atıf Yap

AKIN, A., İRDEM, A., ÖZER, S., AYKAN, H. H., ÇELİKER, A., KARAGÖZ, T. (2022). Results of radiofrequency ablation in children with tachycardia-induced cardiomyopathy. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 7, 625–630. https://ajindex.com/articles/436048

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Gossage AM, Braxton Hicks JA. On auricular fibrillation. QJM 1913; 6: 435-40
  2. Whipple GH, Sheffield LT, Woodman EG, Teophilis C, Friedman S. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. Proc N Engl Cardiovasc Soc 1962; 20: 39-40
  3. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997; 29: 709-15. [Crossref] 4. Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman RE, et al. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol 1986; 57: 563- 70. [Crossref] 5. Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy. Am J Med 2003; 114: 51-5. [Crossref] 6. Houmsse M, Tyler J, Kalbfleisch S. Supraventricular tachycardia causing heart failure. Curr Opin Cardiol 2011; 26: 261-9. [Crossref] 7. Fenelon G, Wijns W, Andries E, Brugada P. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol 1996; 19: 95-106. [Crossref] 8. Semizel E, Ayabakan C, Ceviz N, Çeliker A. Permanent form of junctional reciprocating tachycardia and tachycardia-induced cardiomyopathy treated by catheter ablation: a case report. Turk J Pediatr 2003; 45: 338-41
  4. De Giovanni JV, Dindar A, Griffith MJ, Edgar RA, Silove ED, Stumper O, et al. Recovery pattern of left ventricular dysfunction following radiofrequency ablation of incessant supraventricular tachycardia in infants and children. Heart 1998; 79: 588-92
  5. Arya A, Haghjoo M, Davari P, Sadr-Ameli MA. Resolution of tachycardia-induced cardiomyopathy following ablation of verapamilsensitive idiopathic left ventricular tachycardia. Pediatr Cardiol 2006; 27: 146-8. [Crossref] 11. Vaksmann G, D'Hoinne C, Lucet V, Guillaumont S, Lupoglazoff JM, Chantepie A, et al. Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome. Heart 2006; 92: 101-4. [Crossref] 12. Qi JG, Xing CQ, Liu XQ, Zhang QY, Chen YH, Du JB. Clinical characteristics and follow-up study of tachycardia-induced cardiomyopathy in 12 children. Zhonghua Er Ke Za Zhi 2011; 49: 933-8
  6. Jeong YH, Choi KJ, Song JM, Hwang ES, Park KM, Nam GB, et al. Diagnostic approach and treatment strategy in tachycardiainduced cardiomyopathy. Clin Cardiol 2008; 31: 172-8. [Crossref] 14. Fujino T, Yamashita T, Suzuki S, Sugiyma H, Sagara K, Sawada H, et al. Characteristic